May 22, 1989: NCI’s First Attempt to Genetically Engineer and Modify the Ability of Human Lymphocyte
On May 22, 1989, Dr. Steven A. Rosenberg, a scientist at the National Cancer Institute (NCI), performed the first human gene transfer trial in the history. Dr. Rosenberg implanted the human tumor-infiltrating lymphocytes with a foreign bacterial gene added to human body, and attempted to use genetic engineering to enhance the tracking and cytophagic abilities of lymphocytes.
Reference
https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115